Pelvic Lymph Node Irradiation Including Pararectal Sentinel Nodes for Prostate Cancer Patients: Treatment Optimization Comparing Intensity Modulated X-rays, Volumetric Modulated Arc Therapy, and Intensity Modulated Proton Therapy

被引:15
|
作者
Vees, Hansjorg [1 ]
Dipasquale, Giovanna [1 ]
Nouet, Philippe [1 ]
Zilli, Thomas [1 ]
Cozzi, Luca [2 ]
Miralbell, Raymond [1 ]
机构
[1] Univ Hosp Geneva, Serv Radiat Oncol, Geneva, Switzerland
[2] Oncol Inst Southern Switzerland, Med Phys Unit, Bellinzona, Switzerland
关键词
IMXT; IMPT; Prostate cancer; Sentinel node; SPECT; VMAT; RADIATION-THERAPY; CONFORMAL RADIOTHERAPY; DOSE DISTRIBUTIONS; URINARY TOXICITY; PHOTON; IMRT; CONSENSUS; DELIVERY; RAPIDARC;
D O I
10.7785/tcrt.2012.500405
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We aimed to assess the dosimetric impact of advanced delivery radiotherapy techniques using either intensity modulated x-ray beams (IMXT), volumetric modulated arc therapy (VMAT), or intensity modulated proton therapy (IMPT), for high-risk prostate cancer patients with sentinel nodes in the pararectal region. Twenty high-risk prostate cancer patients were included in a prospective trial evaluating sentinel nodes on pelvic SPECT acquisition. To be eligible for the dosimetric study, patients had to present with pararectal sentinel nodes usually not included in the clinical target volume encompassing the pelvic lymph nodes. Radiotherapy-plans including the prostate, the seminal vesicles, and the pelvic lymph nodes with the pararectal sentinel nodes were optimized for 6 eligible patients. IMXT and IMPT were delivered with 7 and 3 beams respectively and VMAT with 2 arcs. Results were assessed with Dose-Volume Histograms and predictive normal tissue complication probabilities (NTCPs) models between the three competing treatment modalities aiming to deliver a total dose of 50.4 Gy in 1.8 Gy daily fractions. Target coverage was optimized with IMPT when compared to IMXT and VMAT. Coverage of the sentinel node was slightly better with IMXT (D-98% = 57.3 +/- 5.1 Gy) when compared with VMAT (D-98% = 56.2 +/- 4.1 Gy). The irradiation of rectal, bladder, small bowel, and femoral heads volumes was significantly reduced with IMPT when compared to IMXT and VMAT. NTCPs rates for rectal and bladder >= grade-3 late toxicity were better with IMPT (0.4 +/- 0.0% and 0.0 +/- 0.0%) compared with IMXT (4.6 +/- 3.3% and 1.4 +/- 1.1%), and VMAT (4.5 +/- 4.0% and 1.6 +/- 1.6%), respectively. Acceptable dose-volume distributions and low rectal and urinary NTCPs were estimated to geometrically complex pelvic volumes such as the ones proposed in this study using IMXT, VMAT and IMPT. IMPT succeeded, however, to propose the best physical and biological treatment plans compared to both X-ray derived plans.
引用
收藏
页码:181 / 189
页数:9
相关论文
共 50 条
  • [31] Dosimetric Comparisons of Intensity-Modulated Radiotherapy, Volumetric Modulated Arc Therapy, Tomotherapy, Stereotactic Radiosurgery, and Proton Therapy for Treatment of Patients with a Vestibular Schwannoma
    Oh, Yoonjin
    Shin, Dong Oh
    Kong, Moonkyoo
    Shin, Dong Ho
    Chung, Weon Kuu
    Kim, Dong Wook
    JOURNAL OF THE KOREAN PHYSICAL SOCIETY, 2019, 74 (04) : 389 - 398
  • [32] Comparison of photon volumetric modulated arc therapy, intensity-modulated proton therapy, and intensity-modulated carbon ion therapy for delivery of hypo-fractionated thoracic radiotherapy
    Alexander Chi
    Lien-Chun Lin
    Sijin Wen
    Haijuan Yan
    Wen-Chien Hsi
    Radiation Oncology, 12
  • [33] Dosimetric effects of weight loss or gain during volumetric modulated arc therapy and intensity-modulated radiation therapy for prostate cancer
    Pair, Matthew L.
    Du, Weiliang
    Rojas, Hector D.
    Kanke, James E.
    McGuire, Sean E.
    Lee, Andrew K.
    Kuban, Deborah A.
    Kudchadker, Rajat J.
    MEDICAL DOSIMETRY, 2013, 38 (03) : 251 - 254
  • [34] Dosimetric benefits of intensity-modulated radiotherapy and volumetric-modulated arc therapy in the treatment of postoperative cervical cancer patients
    Deng, Xia
    Han, Ce
    Chen, Shan
    Xie, Congying
    Yi, Jinling
    Zhou, Yongqiang
    Zheng, Xiaomin
    Deng, Zhenxiang
    Jin, Xiance
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2017, 18 (01): : 25 - 31
  • [35] Dosimetric effect of collimator rotation on intensity modulated radiotherapy and volumetric modulated arc therapy for rectal cancer radiotherapy
    Abdulameer, Mohammed S.
    Pallathadka, Harikumar
    Menon, Soumya, V
    Rab, Safia Obaidur
    Hjazi, Ahmed
    Kaur, Mandeep
    Sivaprasad, G. V.
    Husseen, Beneen
    Al-Mualm, Mahmood
    Banaei, Amin
    JOURNAL OF X-RAY SCIENCE AND TECHNOLOGY, 2024, 32 (05) : 1331 - 1348
  • [36] Dosimetric comparison of volumetric-modulated arc therapy and intensity-modulated radiation therapy in patients with cervical cancer: a meta-analysis
    Bai, Wei
    Kou, Changgui
    Yu, Weiying
    Li, Yuanyuan
    Hua, Wanqing
    Yu, Lei
    Wang, Jianfeng
    ONCOTARGETS AND THERAPY, 2018, 11 : 7179 - 7186
  • [37] Optimized intensity-modulated arc therapy for prostate cancer treatment
    Ma, LJ
    Yu, CX
    Earl, M
    Holmes, T
    Sarfaraz, M
    Li, XA
    Shepard, D
    Amin, P
    DiBiase, S
    Suntharalingam, M
    Mansfield, C
    INTERNATIONAL JOURNAL OF CANCER, 2001, 96 (06) : 379 - 384
  • [38] Does pelvic lymph nodes irradiation using intensity modulated radiation therapy increase rectal and bladder toxicities in patients with prostate carcinoma?
    Garipagaoglu, M.
    Sengoz, M.
    Senkesen, O.
    Goksel, E. Ozan
    Tezcanli, E.
    Kucucuk, H.
    Aslay, I.
    JOURNAL OF BUON, 2010, 15 (04): : 668 - 673
  • [39] The Dosimetric Performance of Volumetric Modulated Arc Therapy and Intensity Modulated Radiation Therapy in the Treatment of Locally Advanced Laryngeal Cancer
    Khater, Firas
    Attalla, Ehab
    Elshemey, Wael
    Mohammed, Haitham
    MIDDLE EAST JOURNAL OF CANCER, 2024, 15 (01) : 25 - 39
  • [40] Dosimetric analysis of testicular doses in prostate intensity-modulated and volumetric-modulated arc radiation therapy at different energy levels
    Onal, Cem
    ArsIan, Gungor
    Dolek, Yemliha
    Efe, Esma
    Medical Dosimetry, 2016, 41 (04) : 310 - 314